This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
We have now added a new section called the "Assay History List" to the "At A Gla...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...